GAITHERSBURG, Md., April 21, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced that Chad Rubin has been appointed to the newly created position of Senior Vice President, Corporate Affairs. Mr. Rubin will be responsible for all corporate communications, along with involvement in investor and capital markets activities. He joins NexImmune with more than 20 years of experience in investor relations, investment banking and capital markets within the biotechnology sector.
{iframe}https://www.globenewswire.com/news-release/2021/04/21/2214026/0/en/NexImmune-Appoints-Chad-Rubin-as-Senior-Vice-President-Corporate-Affairs.html{/iframe}